公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2002 | P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection | LIANG, JIN-TUNG; 鄭安理 | INTERNATIONAL JOURNAL OF CANCER | | | |
2016 | Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study | Zhu, A.; Knox, J.; Kudo, M.; Chan, S.; Finn, R.; Siegel, A.; Ma, J.; Watson, P. A.; Cheng, A-L.; 鄭安理 | Annals of Oncology | 0 | 2 | |
1992 | Peripheral T-Cell Lymphoma and Adult T-Cell Lymphoma/Leukemia | Cheng, Ann-Lii; 鄭安理 | Current Therapy for Hematology/Oncology | | | |
2006 | Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer | CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; 鄭安理 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | | | |
2005 | A Phase Ii Study in Taiwan with Navelbine(Nvb) Oral in Combinatino with Cisplatin (C) in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients | YU, CHONG-JEN; YANG, CHIH-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR; 鄭安理; 楊泮池 | LUNG CANCER | | | |
2009 | A Phase Ii Study of Gemcitabine-Based Chemoradiotherapy (Ccrt) after Triplet Induction Chemotherapy (Ict) for Locally Advanced Pancreatic Cancer (Lapc): A Taiwan Cooperative Oncology Group (Tcog) Study | CHENG, ANN-LII; CHEN, LI-TZONG; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2007 | Phase Ii Trial of the Efficacy and Safety of Sunitinib Malate Monotherapy in Unresectable Hepatocellular Carcinoma | CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2015 | Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) | Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Journal of Clinical Oncology | 0 | 0 | |
2013 | Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model. | Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma. | Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | J. Clin. Oncol. | | | |
2001 | Prospective Study of Helicobacter Pylori Eradication Therapy in Stage I-E High-Grade Mucosa-Associated Lymphoid Tissue Lymphoma of the Stomach | LIN, JAW-TOWN; SU, IH-JEN; CHENG, ANN- LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2013 | Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study | Ueno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG ; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M.; 鄭安理 | Journal of Clinical Oncology | 508 | 467 | |
2015 | Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer | Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 鄭安理 | J. Clin. Oncol. | | | |
1998 | Research Nurses for Clinical Trials of Anti-Cancer Drugs: Developing a New Subspecialty in Taiwan | CHENG, ANN-LII; LAI, YEUR-HUR; YU, YU-CHIEH; 鄭安理 | DRUG INFORMATION JOURNAL | | | |
1994 | Retinoic Acid-Induced Apoptosis and Regression of a Refractory EB Virus-Containing T Cell Lymphoma Expressing Multidrug-Resistance Phenotypes | Cheng, Ann-Lii; Lay, J. D.; Su, I. J.; 鄭安理 | British Journal of Haematology | | | |
2000 | Retinoic Acid-Induced Apoptotic Pathway in T-Cell Lymphmoa : Identification of Four Groups of Genes with Differential Biological Function | WANG, KAO-CHUNG; CHENG, ANN-LII; CHUANG, SHUANG-EN; HSU, HEY-CHI; SU, IH-JEN; 鄭安理 | EXPERIMENTAL HEMATOLOGY | | | |
2014 | Risk of second primary malignancies in young patients with colorectal cancer | Wu, Hsu; Liang, Yi-Hsin; Shao, Yu Yun; Chen, Ho-Min; Lai, Chiu-Lin; Lin, Zhong-Zhe; Shau, Wen-Yi; Yeh, Kun-Huol; Chong, Ann-Lii; Lal, Mei-Shu; 鄭安理; 葉坤輝 | J. Clin. Oncol. | | | |
2012 | THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS | Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 鄭安理; 徐志宏 | Ann. Oncol. | | | |
2011 | Signal transducer and activator of transcription 3 is a major kinase- independent target of sorafenib in hepatocellular carcinoma=STAT3為 Sorafenib於肝癌的主要標的 | TAI, WEI-TIEN; CHENG, ANN-LII; SHIAU, CHUNG-WAI; HUANG, HSIANG-PO; HUANG, JUI-WEN; CHEN, PEI-JER; CHEN, KUEN-FENG; 鄭安理; 陳培哲 | Journal of Hepatology | | | |
2008 | Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | HEPATOLOGY | | | |